These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33825879)

  • 61. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
    Salzman MB; Huang CW; O'Brien CM; Castillo RD
    Emerg Infect Dis; 2021 Jul; 27(7):1944-1948. PubMed ID: 34034858
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Science and religion for COVID-19 vaccine promotion.
    Galang JRF
    J Public Health (Oxf); 2021 Sep; 43(3):e513-e514. PubMed ID: 33866364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implementation of State Vaccine Incentive Lottery Programs and Uptake of COVID-19 Vaccinations in the United States.
    Acharya B; Dhakal C
    JAMA Netw Open; 2021 Dec; 4(12):e2138238. PubMed ID: 34882179
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Risk of Resurgence in Vaccine-Preventable Infections Due to Coronavirus Disease 2019-Related Gaps in Immunization.
    Feldman AG; O'Leary ST; Danziger-Isakov L
    Clin Infect Dis; 2021 Nov; 73(10):1920-1923. PubMed ID: 33580243
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hypersensitivity Reactions to Vaccines: Current Evidence and Standards for SARS-CoV-2 Vaccines.
    Carvalho JC; Cunha F; Coutinho IA; Loureiro C; Faria E; Bom AT
    Acta Med Port; 2021 Jun; 34(7-8):541-547. PubMed ID: 34851819
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The world's largest COVID-19 vaccination campaign.
    Bagcchi S
    Lancet Infect Dis; 2021 Mar; 21(3):323. PubMed ID: 33639124
    [No Abstract]   [Full Text] [Related]  

  • 67. Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy.
    French J; Deshpande S; Evans W; Obregon R
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32823775
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.
    Rotondo JC; Martini F; Maritati M; Mazziotta C; Di Mauro G; Lanzillotti C; Barp N; Gallerani A; Tognon M; Contini C
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578269
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Key populations for early COVID-19 immunization: preliminary guidance for policy.
    Ismail SJ; Zhao L; Tunis MC; Deeks SL; Quach C;
    CMAJ; 2020 Nov; 192(48):E1620-E1632. PubMed ID: 33144317
    [No Abstract]   [Full Text] [Related]  

  • 70. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.
    Hughes K; Gogineni V; Lewis C; Deshpande A
    Curr Med Res Opin; 2021 Jun; 37(6):907-909. PubMed ID: 33760673
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fight against hesitancy: public health concern towards COVID-19 vaccine.
    Punsalan MLD
    J Public Health (Oxf); 2021 Jun; 43(2):e372. PubMed ID: 33730162
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vaccination in the Philippines: experiences from history and lessons for the future.
    Reyes MSGL; Dee EC; Ho BL
    Hum Vaccin Immunother; 2021 Jun; 17(6):1873-1876. PubMed ID: 33357156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Vaccinations].
    Wendt S; Trawinski H; Pietsch C; Borte M; Lübbert C
    Internist (Berl); 2021 Dec; 62(12):1295-1309. PubMed ID: 34709421
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Ethical issues of vaccination against Sars-CoV-2].
    Delfraissy JF; Duée PH
    Rev Infirm; 2022 Mar; 71(279):26-27. PubMed ID: 35397837
    [TBL] [Abstract][Full Text] [Related]  

  • 75. COVID-19 Vaccinations: Medical, Ethical and Legal Aspects.
    Alazzam FAF; Shakatreh HJM; Gharaibeh ZIY; Aldrou KKAR; Alkhatib AJ
    Med Arch; 2022 Dec; 76(6):413-418. PubMed ID: 36937616
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Severe breakthrough COVID-19 infections in Scotland-implications for immunisation programmes.
    Leshem E; Nelson K; Lopman BA
    Lancet Respir Med; 2021 Dec; 9(12):1354-1356. PubMed ID: 34599904
    [No Abstract]   [Full Text] [Related]  

  • 77. COVID-19 in Romania: What Went Wrong?
    Dascalu S; Geambasu O; Valentin Raiu C; Azoicai D; Damian Popovici E; Apetrei C
    Front Public Health; 2021; 9():813941. PubMed ID: 34976942
    [No Abstract]   [Full Text] [Related]  

  • 78. COVID-19 Vaccination and Cancer: Correspondence.
    Mungmunpuntipantip R; Wiwanitkit V
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3417. PubMed ID: 34837894
    [No Abstract]   [Full Text] [Related]  

  • 79. Covid-19 Massive Vaccination Center Layouts.
    Brambilla A; Mangili S; Macchi M; Trucco P; Perego A; Capolongo S
    Acta Biomed; 2021 Oct; 92(S6):e2021446. PubMed ID: 34739468
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling.
    Harvard S; Winsberg E; Symons J; Adibi A
    Soc Sci Med; 2021 Oct; 286():114323. PubMed ID: 34428600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.